Tin tức & Cập nhật

Pembrolizumab + chemo emerging as first-line SoC in advanced oesophageal cancer

05 Oct 2020 bởi

Pembrolizumab in combination with chemotherapy significantly improves overall survival (OS), progression-free survival (PFS) and objective response rate (ORR) vs chemotherapy alone in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer, according to results of the phase III KEYNOTE-590 study presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020.

Pembrolizumab + chemo emerging as first-line SoC in advanced oesophageal cancer

05 Oct 2020

Serum assessment detects nonadherence to adjuvant tamoxifen in early breast cancer

05 Oct 2020 bởi

Serum assessment of drug level may detect early nonadherence to adjuvant tamoxifen therapy and identify patients with early breast cancer at risk of poorer outcomes, new data from the CANTO study have shown.

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Pembrolizumab + chemo emerging as first-line SoC in advanced oesophageal cancer

Pembrolizumab + chemo emerging as first-line SoC in advanced oesophageal cancer

Serum assessment detects nonadherence to adjuvant tamoxifen in early breast cancer

Serum assessment detects nonadherence to adjuvant tamoxifen in early breast cancer

Severe amino acid loss seen in patients on extracorporeal haemodialysis

Severe amino acid loss seen in patients on extracorporeal haemodialysis

Erectile dysfunction in healthy men more likely related to depression than MetS

Erectile dysfunction in healthy men more likely related to depression than MetS

Poor sleep shortens telomeres in older adults

Poor sleep shortens telomeres in older adults

45-percent cutoff in fat, sugar intake identifies low-quality diets

45-percent cutoff in fat, sugar intake identifies low-quality diets

Obesity not a reason for aggressive levofloxacin dosing for febrile neutropaenia prophylaxis

Obesity not a reason for aggressive levofloxacin dosing for febrile neutropaenia prophylaxis

Sacubitril/valsartan cost-effective for HFREF patients

Sacubitril/valsartan cost-effective for HFREF patients

Choline supplementation carries increased T2D risk in women but not in men

Choline supplementation carries increased T2D risk in women but not in men

Anti-VEGF shows long-term potential against neovascular AMD

Anti-VEGF shows long-term potential against neovascular AMD